Regulatory assessment modifies cyflumetofen levels in sweet peppers, indicating low risk for consumers.
In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Certis Belchim BV submitted a request to the competent national authority in the Netherlands to modify the existing maximum residue level (MRL) for the active substance cyflumetofen in sweet peppers/bell peppers. The data submitted in support of the request were found to be sufficient to derive an MRL proposal for sweet peppers/bell peppers. Adequate analytical methods for enforcement are available to control the residues of cyflumetofen (sum of isomers) in plant matrices at the validated limit of quantification (LOQ) of 0.01 mg/kg. Based on the risk assessment results, EFSA concluded that the short‐term and long‐term intake of residues resulting from the uses of cyflumetofen according to the reported agricultural practices is unlikely to present a risk to consumer health.
No takes yet. Share an insight, caveat, or question.
(EFSA) et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: